Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, José Carlos Nicolau, Michelle N. Gong et al.|Bristol Research (University of Bristol)|2021Cited by 589
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C. Goligher, Allen Cheng, Patrick R. Lawler et al.|JAMA|2023Cited by 98
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L. Houston, Ryan Zarychanski, Patrick R. Lawler et al.|Clinical Trials|2020Cited by 68